You are here: Home » International » News » Others
Business Standard

Japan health panel recommends approval of Pfizer coronavirus vaccine

Health Minister Norihisa Tamura says a formal approval is expected Sunday

Topics
Japan | Pfizer | Coronavirus Vaccine

AP  |  Tokyo 

Pfizer
Pfizer plans to ask the Food and Drug Administration for emergency authorization of the two-dose vaccine later this month

Japan's health minister says the efficacy of vaccine was endorsed by a ministry panel, paving the way for a final approval within days.

Health Minister Norihisa Tamura says a formal approval is expected Sunday. The vaccine is already administered in the U.S. and many other countries since December.

Vaccines are considered key to holding the delayed Olympics this summer. is expected to receive 144 million doses from Pfizer, 120 million from AstraZeneca and about 50 million from Moderna before the end of this year, enough to cover its population.

must rely on imports, many subject to the EU's export control, and a cause for concern about supplies. Vaccines developed by are still in the early stages.

About 20,000 front-line medical workers at hospitals in Japan will get their first shots beginning the middle of next week.

About 3 million other medical workers will be next, followed by elderly people getting their shots in April. By June, it's expected all will be eligible.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, February 12 2021. 22:00 IST
RECOMMENDED FOR YOU
.